---
$id: https://graph.org.ai/products/commodity/51131724
$type: Product
source: UNSPSC
code: "51131724"
title: "Midazogrel"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Midazogrel

**UNSPSC Code**: 51131724
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C18H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04HCK0SD2O, chemically known as 1h-imidazole, 1-(3-(phenylmethoxy)-1-octenyl)-, (e)- but generally known as midazogrel, which bears US NIH Compound Identifier 6436121. European Medicines Agency schedules Midazogrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08949MIG. The term MIDAZOGREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). MIDAZOGREL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule midazogrel under HS 29332990 and SITC 51573. As of Q4 2014, MIDAZOGREL remains the US FDA Preferred Term for this commodity. Midazogrel bears US NLM identifiers UMLS ID C1881826 and NCI Concept Code C66148. SMILES: O(C(CCCCC)/C=C/N1CCNC1)CC1CCCCC1.

